4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-013042
CHIEF FINANCIAL OFFICER gave up 1,338 shares (to pay taxes)
- CHIEF FINANCIAL OFFICER acquired 4,556 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2023-09-01 | Option exercise | +2,695 | 15,109 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2023-09-01 | Shares withheld for taxes | −791 | $17.76 | $14,048 | 14,318 | D |
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2023-09-02 | Option exercise | +1,861 | 16,179 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2023-09-02 | Shares withheld for taxes | −547 | $17.76 | $9,715 | 15,632 | D |
| Derivatives | |||||||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2023-09-01 | Option exercise · Restricted Share Unit | −2,695 | 8,082 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2023-09-01 | Grant or award · Restricted Share Unit | +7,000 | 7,000 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2023-09-01 | Grant or award · Share Option | +42,050 | 42,050 | D | ||
| Ragosa Mark CHIEF FINANCIAL OFFICER | 2023-09-02 | Option exercise · Restricted Share Unit | −1,861 | 3,722 | D | ||
Loading xslF345X05/form4-09062023_110953.xml…